OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 25 citing articles:

Programmed death receptor (PD-)1/PD-ligand (L)1 in urological cancers : the “all-around warrior” in immunotherapy
Qiang Liu, Yujing Guan, Shenglong Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 17

Emerging therapeutic frontiers in cancer: insights into posttranslational modifications of PD-1/PD-L1 and regulatory pathways
Rong Wang, Shiwei He, Jun Long, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Small non-coding RNA profiling in patients with non-muscle invasive bladder cancer
Jiajia Cai, Zeqin Yan, Yadi Zhong, et al.
BMC Cancer (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1

The role of tumor-derived exosomal LncRNA in tumor metastasis
Zhongren Yu, Jiali Fu, Vanya Mantareva, et al.
Cancer Gene Therapy (2025)
Closed Access | Times Cited: 1

LncRNA PRBC induces autophagy to promote breast cancer progression through modulating PABPC1-mediated mRNA stabilization
Yiran Liang, Bing Chen, Fanchao Xu, et al.
Oncogene (2024) Vol. 43, Iss. 14, pp. 1019-1032
Closed Access | Times Cited: 4

Non-Coding RNAs in Urinary Bladder Cancer Microenvironment: Diagnostic, Therapeutic, and Prognostic Perspective
Enas A. El Saftawy, Basma Emad Aboulhoda, Marwa Ali Abd Elkhalek, et al.
Pathology - Research and Practice (2025) Vol. 266, pp. 155815-155815
Closed Access

MicroRNAs in pancreatic cancer drug resistance: mechanisms and therapeutic potential
Fangying Dong, Jing Zhou, Yijie Wu, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access

BAP1-mediated ubiquitination inhibition and CAS6/AXL signaling activation in bladder cancer progression
Chen Liang, Zhenjun Liu
Cytotechnology (2025) Vol. 77, Iss. 3
Closed Access

Cigarette smoking combined with genetic variation regulates the m6A methylation of CRNKL1 and is associated with bladder cancer risk
Jialei Yang, Zihan Ji, Fang Gao, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 5, pp. 2782-2793
Closed Access | Times Cited: 2

Programmed Death Ligand 1 Regulatory Crosstalk with Ubiquitination and Deubiquitination: Implications in Cancer Immunotherapy
Soon-Bin Kim, Soonjae Hwang, Ji-Young Cha, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2939-2939
Open Access | Times Cited: 2

Enhancing m6A modification of lncRNA through METTL3 and RBM15 to promote malignant progression in bladder cancer
Yapeng Huang, Yifan Lv, Baotong Yang, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28165-e28165
Open Access | Times Cited: 2

Exploring the Utility of Long Non-Coding RNAs for Assessing the Health Consequences of Vaping
Ahmad Besaratinia, Hannah Blumenfeld, Stella Tommasi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8554-8554
Open Access | Times Cited: 2

AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility
Yanping Xiao, Yang Shen, Hui Song, et al.
Archives of Toxicology (2024) Vol. 98, Iss. 7, pp. 2269-2279
Closed Access | Times Cited: 1

Decoding LncRNA in COPD: Unveiling Prognostic and Diagnostic Power and Their Driving Role in Lung Cancer Progression
Osama Sweef, Reda Z. Mahfouz, Tülin Taşcıoğlu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 9001-9001
Open Access | Times Cited: 1

Heterogeneity of modulatory immune microenvironment in bladder cancer
Enas El Saftawy, Basma Emad Aboulhoda, Mansour A. Alghamdi, et al.
Tissue and Cell (2024) Vol. 93, pp. 102679-102679
Closed Access | Times Cited: 1

LncRNA GATA3-AS1 Promotes Bladder Uroepithelial Cancer Progression by Stabilizing DDX5
Yong Duan, Zonghang Liu, Yongliang Ma, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 835-847
Open Access | Times Cited: 1

Roles of LncRNA ARSR in tumor proliferation, drug resistance, and lipid and cholesterol metabolism
Zhicheng Li, Dan Wang, Xiaojun Zhu
Clinical & Translational Oncology (2024)
Closed Access

USP18 Is Associated with PD-L1 Antitumor Immunity and Improved Prognosis in Colorectal Cancer
Cili Jifu, Linxia Lü, Jiaxin Ding, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1191-1191
Open Access

USP18 promotes the proliferation, invasion, and migration of head and neck squamous cell carcinoma by deubiquitinating PLK1
Liang Geng, Fangfang Liu, Liyun Yang, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 2, pp. 114284-114284
Open Access

Non-coding RNAs in bladder cancer, a bridge between gut microbiota and host?
Jun Zou, Baisheng Xu, Peiyue Luo, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1

Scroll to top